combretastatin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoccia, A; Leone, S; Méndez-Callejas, GM; Tanzarella, C | 1 |
| Edelman, MJ | 1 |
1 review(s) available for combretastatin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Bibenzyls; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Resistance, Neoplasm; Epothilones; Humans; Lung Neoplasms; Paclitaxel; Polyglutamic Acid; Tubulin Modulators; Vinblastine; Vinorelbine | 2009 |
1 other study(ies) available for combretastatin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Carcinoma, Non-Small-Cell Lung; Cytochromes c; Humans; Lung Neoplasms; Mitochondria; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2014 |